Illinois Dupixent Safety Monitoring

Updated March 2026

Current Monitoring Focus

Monitoring in Illinois focuses on patient reports, diagnosis timelines, and whether additional risk warnings or formal litigation activity emerge.

Who Should Register for Updates in Illinois

• Documented Dupixent use followed by cancer diagnosis.
• Diagnosis of lymphoma, skin cancer, breast cancer, lung cancer, or another malignancy.
• Medical records supporting treatment timeline and diagnosis timing.
• Interest in receiving updates if litigation activity expands.